Insider Title Company Date Price Return Shares Value
Decheng Capital Global Life Sciences Fund Iv, L.P. Non-Executive Aardvark Therapeutics, Inc. (AARD) 2025-02-14 $16.00 0.0% 1,250,000 $20,000,000
Decheng Capital Global Life Sciences Fund Iv, L.P. Non-Executive CG Oncology, Inc. (CGON) 2024-01-29 $19.00 97.7% 400,000 $7,600,000
Return Profit / (loss) Cost
Total 26.9% $7,424,000 $27,600,000